Frankfurt - Delayed Quote EUR

Vetoquinol SA (8JM.F)

72.20

-1.70

(-2.30%)

As of 8:03:47 AM GMT+2. Market Open.

Vetoquinol: Availability of the 2024 Universal Registration Document

LURE, France, April 25, 2025--Regulatory News: On 24 April 2025, Vetoquinol (Paris:VETO) filed its 2024 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

Business Wire 28 days ago

VETOF
Vetoquinol Group: Sales for 1st Quarter 2025

LURE, France, April 25, 2025--Regulatory News: Vetoquinol Group (Paris:VETO):

Business Wire 28 days ago

VETOF
Vetoquinol: Annual Results 2024

LURE, France, March 20, 2025--Regulatory News: Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), commented: "In 2024, we delivered a solid financial year, combining growth in almost all our reference markets, high profitability and sustained cash generation. We have achieved this performance while absorbing the sometimes significant uncertainties, such as in the United States this year, as well as the cost of transforming the Group. This is due to the strength of our model built aro

Business Wire 2 months ago

VETOF
Vetoquinol: Annual Sales 2024

LURE, France, January 30, 2025--Regulatory News: Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), commented: "All our activities and territories are growing, with the exception of the United States for one-off reasons. We are on track to deliver long-term profitable growth. We owe this to our focus strategy and the power of our "Essentials" model, which has delivered average annual growth of over 8% for the past 10 years. We will continue to pursue this strategy in 2025."

Business Wire 3 months ago

VETO.PA
Vetoquinol: 2025 Calendar of Financial Communication

LURE, France, January 15, 2025--Regulatory News: Vetoquinol (Paris:VETO) published its calendar of financial communication for 2025.

Business Wire 4 months ago

VETO.PA
Vetoquinol: Sales at End September 2024

LURE, France, October 30, 2024--Regulatory News: At the end of September 2024, Vetoquinol (Paris:VETO) sales totaled €398 million, up +1.6% on a reported basis and +1.8% at constant exchange rates. Over the same period, the laboratory recorded net negative currency impacts of €-1 million, linked to the Americas and Asia Pacific/Rest of World territories, partially offset by positive currency impacts of +1.4M€ on the Europe territory.

Business Wire 6 months ago

VETO.PA
VETOQUINOL CANADA ANNOUNCES THE LAUNCH OF FLEXADIN® ESSENTIAL, AN EVOLUTION OF THE FLEXADIN LINE

Dear Valued Partner,

CNW Group 7 months ago

VETO.PA
Vetoquinol: 2024 Half-year Results

LURE, France, September 12, 2024--Regulatory News: The Board of Directors of Vetoquinol SA (Paris:VETO) met on September 10, 2024 to review business activity and approve the financial statements for the first half of 2024. The auditors have released their first half limited review report.

Business Wire 8 months ago

VETO.PA

Performance Overview

Return	8JM.F	CAC 40 (^FCHI)
YTD	-5.87%	+6.17%
1-Year	-30.00%	-3.29%
3-Year	-41.76%	+23.23%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vetoquinol SA (8JM.F)

Vetoquinol: Availability of the 2024 Universal Registration Document

Vetoquinol Group: Sales for 1st Quarter 2025

Vetoquinol: Annual Results 2024

Vetoquinol: Annual Sales 2024

Vetoquinol: 2025 Calendar of Financial Communication

Vetoquinol: Sales at End September 2024

VETOQUINOL CANADA ANNOUNCES THE LAUNCH OF FLEXADIN® ESSENTIAL, AN EVOLUTION OF THE FLEXADIN LINE

Vetoquinol: 2024 Half-year Results

Performance Overview